|
US4690915A
(en)
|
1985-08-08 |
1987-09-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Adoptive immunotherapy as a treatment modality in humans
|
|
US5217891A
(en)
|
1987-07-28 |
1993-06-08 |
Chiron Corporation |
DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
|
|
ATE127345T1
(de)
|
1988-06-15 |
1995-09-15 |
Whitehead Biomedical Inst |
Stressproteine und verwendungen dafür.
|
|
WO1990002564A1
(en)
|
1988-09-12 |
1990-03-22 |
Codon |
Vaccine diagnostic employing proteins homologous to heat shock proteins of trypanosoma cruzi
|
|
US5232833A
(en)
|
1988-09-14 |
1993-08-03 |
Stressgen Biotechnologies Corporation |
Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
|
|
JPH04503309A
(ja)
|
1989-07-28 |
1992-06-18 |
アメリカ合衆国 |
効果的な方向性遺伝子クローニング系
|
|
GB9007194D0
(en)
|
1990-03-30 |
1990-05-30 |
Wellcome Found |
Live vaccines
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5188964A
(en)
|
1990-04-12 |
1993-02-23 |
Board Of Regents, The University Of Texas System |
Method and kit for the prognostication of breast cancer patient via heat shock/stress protein determination
|
|
WO1992008488A1
(en)
|
1990-11-08 |
1992-05-29 |
University College London |
Mycobacterium as adjuvant for antigens
|
|
GB9016315D0
(en)
|
1990-07-25 |
1990-09-12 |
Burnie James P |
Medicaments
|
|
GB9024320D0
(en)
|
1990-11-08 |
1990-12-19 |
Univ London |
Treatment of uveitis
|
|
GB2251186A
(en)
|
1990-12-04 |
1992-07-01 |
Randall Neal Gatz |
Polypeptide for use in treatment of autoimmune disease
|
|
US5177942A
(en)
|
1991-08-15 |
1993-01-12 |
The Toro Company |
Mower deck with improved belt drive arrangement
|
|
GB9200949D0
(en)
|
1992-01-17 |
1992-03-11 |
Medical Res Council |
Diagnostic peptides
|
|
FR2688227A1
(fr)
|
1992-03-04 |
1993-09-10 |
Inst Nat Sante Rech Med |
Proteines formant des complexes avec des chaperones et leurs ligands, leurs fragments, leur obtention et leurs applications biologiques.
|
|
IT1262896B
(it)
|
1992-03-06 |
1996-07-22 |
|
Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
|
|
CA2130089A1
(en)
|
1992-03-09 |
1993-09-16 |
Aldo Mancini |
Protein compound, coding nucleotide sequences, producing cell line and uses thereof
|
|
JPH07505719A
(ja)
|
1992-04-14 |
1995-06-22 |
デューク・ユニバーシティー |
ｐ５３及びＨＳＰ７０のコンプレックスを含む腫瘍の検出方法
|
|
JPH07509694A
(ja)
|
1992-05-14 |
1995-10-26 |
ベイラー・カレッジ・オブ・メディシン |
突然変異したステロイドホルモン受容体，その使用方法および遺伝子治療のための分子スイッチ
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
WO1994003599A1
(fr)
|
1992-08-04 |
1994-02-17 |
Sagami Chemical Research Center |
ADNc HUMAIN ET PROTEINE POUR LAQUELLE CODE CET ADNc
|
|
GB2270076A
(en)
|
1992-08-18 |
1994-03-02 |
Univ Manchester |
Human HSP 90 Epitopes
|
|
GB9223816D0
(en)
|
1992-11-13 |
1993-01-06 |
Medical Res Council |
Heat shock proteins and the treatment of tumours
|
|
WO1994021808A1
(de)
|
1993-03-19 |
1994-09-29 |
Boehringer Ingelheim International Gmbh |
Verfahren zur herstellung von krebsvakzinen
|
|
US5496934A
(en)
|
1993-04-14 |
1996-03-05 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Nucleic acids encoding a cellulose binding domain
|
|
US6004941A
(en)
|
1993-06-14 |
1999-12-21 |
Basf Aktiengesellschaft |
Methods for regulating gene expression
|
|
WO1995004824A1
(en)
|
1993-08-05 |
1995-02-16 |
Medvet Science Pty. Ltd. |
Generation of dna libraries and retroviral vectors for same
|
|
US5705159A
(en)
|
1993-08-31 |
1998-01-06 |
John Wayne Cancer Institute |
Immunoreactive peptide sequence from a 43 KD human cancer antigen
|
|
US5997873A
(en)
|
1994-01-13 |
1999-12-07 |
Mount Sinai School Of Medicine Of The City University Of New York |
Method of preparation of heat shock protein 70-peptide complexes
|
|
US5750119A
(en)
|
1994-01-13 |
1998-05-12 |
Mount Sinai School Of Medicine Of The City University Of New York |
Immunotherapeutic stress protein-peptide complexes against cancer
|
|
US5961979A
(en)
|
1994-03-16 |
1999-10-05 |
Mount Sinai School Of Medicine Of The City University Of New York |
Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
|
|
EP0769932B1
(en)
|
1994-07-08 |
1998-10-14 |
Baxter International Inc. |
Implanted device containing tumor cells for the treatment of cancer
|
|
US5772995A
(en)
|
1994-07-18 |
1998-06-30 |
Sidney Kimmel Cancer Center |
Compositions and methods for enhanced tumor cell immunity in vivo
|
|
ATE197765T1
(de)
|
1994-10-03 |
2000-12-15 |
Us Gov Health & Human Serv |
Zusammensetzung enthaltend ein antigen exprimierendes rekombinantes virus und ein immunstimulierendes molekül exprimierendes rekombinantes virus
|
|
US5703057A
(en)
|
1995-04-07 |
1997-12-30 |
Board Of Regents The University Of Texas System |
Expression library immunization
|
|
US6331299B1
(en)
|
1995-08-18 |
2001-12-18 |
Sloan-Kettering Institute For Cancer Research |
Method for treatment of cancer and infectious disease and compositions useful in same
|
|
JP4163253B2
(ja)
|
1995-08-18 |
2008-10-08 |
スローン−ケッタリング インスティチュート フォー キャンサー リサーチ |
熱ショックタンパク質に基づくワクチンおよび免疫療法
|
|
US6719974B1
(en)
|
1995-08-18 |
2004-04-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
US6761892B1
(en)
|
1995-08-18 |
2004-07-13 |
Sloan-Kettering Institute For Cancer Research |
Heat shock protein-based vaccines and immunotherapies
|
|
EP0851765A4
(en)
|
1995-09-13 |
2000-01-19 |
Univ Fordham |
THERAPEUTIC AND PROPHYLACTIC PROCESSES THAT USE HEAT SHOCK PROTEINS
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
WO1997026910A2
(de)
|
1996-01-27 |
1997-07-31 |
Max-Delbrück-Centrum für Molekulare Medizin |
Tumorimpfstoff für die immuntherapie von malignen tumoren
|
|
DE19602985A1
(de)
|
1996-01-27 |
1997-07-31 |
Max Delbrueck Centrum |
Tumorzellimpfstoff für die Immuntheraphie von malignen Tumoren
|
|
AU734196B2
(en)
|
1996-03-28 |
2001-06-07 |
Whitehead Institute |
Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
|
|
US5747332A
(en)
|
1996-09-20 |
1998-05-05 |
University Of New Mexico |
Methods for purifying and synthesizing heat shock protein complexes
|
|
US6130087A
(en)
|
1996-10-07 |
2000-10-10 |
Fordham University |
Methods for generating cytotoxic T cells in vitro
|
|
DE69735376T2
(de)
|
1996-11-26 |
2006-12-14 |
Stressgen Biotechnologies Corp., Victoria |
Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US6015709A
(en)
|
1997-08-26 |
2000-01-18 |
Ariad Pharmaceuticals, Inc. |
Transcriptional activators, and compositions and uses related thereto
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
ES2355483T3
(es)
|
1998-02-20 |
2011-03-28 |
University Of Miami |
Complejo de proteina de choque térmico modificada-péptido antigénico.
|
|
US5989910A
(en)
|
1998-08-03 |
1999-11-23 |
University Of Lausanne |
Potent genetic switch allowing regulated gene expression in eukaryotic cells
|
|
US6451316B1
(en)
|
1998-10-05 |
2002-09-17 |
University Of Conneticut Health Center |
Methods for generating antigen-reactive T cells in vitro
|
|
US6797480B1
(en)
|
1998-10-05 |
2004-09-28 |
University Of Connecticut Health Center |
Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
US6734172B2
(en)
*
|
1998-11-18 |
2004-05-11 |
Pacific Northwest Research Institute |
Surface receptor antigen vaccines
|
|
EP2332976B1
(en)
*
|
1999-02-03 |
2014-04-02 |
Amgen, Inc |
Novel polypeptides involved in immune response
|
|
CN101070540B
(zh)
*
|
2000-04-28 |
2015-04-01 |
约翰霍普金斯大学 |
新的树突状细胞共刺激分子
|
|
US7132109B1
(en)
|
2000-10-20 |
2006-11-07 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
CA2452517A1
(en)
|
2001-07-11 |
2003-01-23 |
University Of Miami |
Recombinant vsv for the treatment of tumor cells
|
|
HK1079705A1
(zh)
*
|
2001-08-20 |
2006-04-13 |
University Of Connecticut Health Center |
包含用於治疗癌症及感染性疾病的热休克蛋白或α2-巨球蛋白的组合物制备方法
|
|
AU2002364935A1
(en)
*
|
2001-10-09 |
2003-06-23 |
Mayo Foundation For Medical Education And Research |
Enhancement of immune responses by 4-1bb-binding agents
|
|
WO2003053338A2
(en)
|
2001-11-16 |
2003-07-03 |
The Government Of The Usa As Represented By The Secretary Of The Dept. Of Health And Human Services |
Novel chimeric rev, tat, and nef antigens
|
|
WO2003057171A2
(en)
*
|
2002-01-03 |
2003-07-17 |
The Trustees Of The University Of Pennsylvania |
Activation and expansion of t-cells using an engineered multivalent signaling platform
|
|
WO2003063801A2
(en)
|
2002-02-01 |
2003-08-07 |
Thomas Jefferson University |
Treatment of tumor cells for use in immunotherapy of cancer
|
|
CN1440812A
(zh)
*
|
2002-02-27 |
2003-09-10 |
上海中信国健药业有限公司 |
一种使用cd137结合激动剂增强免疫应答的方法
|
|
EP1578773A3
(en)
*
|
2002-02-28 |
2005-12-14 |
Antigenics Inc. |
Methods and products based on oligomerization of stress proteins
|
|
IL164376A0
(en)
*
|
2002-04-03 |
2005-12-18 |
Applied Research Systems |
Ox4or binding agents, their preparation and pharmaceutical compositions containing them
|
|
AU2003231098A1
(en)
*
|
2002-04-25 |
2003-11-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
*
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
ES2295639T3
(es)
*
|
2002-06-13 |
2008-04-16 |
Crucell Holland B.V. |
Agonistas del receptor ox40=(=cd134) y uso terapeutico descripcion.
|
|
AU2003285863A1
(en)
|
2002-10-09 |
2004-05-04 |
Central Iowa Health System |
Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase
|
|
US20040197312A1
(en)
*
|
2003-04-02 |
2004-10-07 |
Marina Moskalenko |
Cytokine-expressing cellular vaccine combinations
|
|
US8541002B2
(en)
*
|
2003-09-12 |
2013-09-24 |
Agenus Inc. |
Vaccine for treatment and prevention of herpes simplex virus infection
|
|
AU2004275814A1
(en)
|
2003-09-26 |
2005-04-07 |
University Of Miami |
Tumor vaccine
|
|
US20070141666A1
(en)
|
2003-09-26 |
2007-06-21 |
Applied Research Systems Ars Holding N.V. |
Leader sequences for use in production of proteins
|
|
CA2548347A1
(en)
*
|
2003-12-11 |
2005-06-30 |
Sidney Kimmel Cancer Center |
Methods for generating immunity to antigen
|
|
FR2867982B1
(fr)
|
2004-03-26 |
2007-07-20 |
Jean Marie Andrieu |
Procede pour amplifier l'activite de vaccins therapeutiques
|
|
WO2005124346A1
(en)
*
|
2004-05-17 |
2005-12-29 |
The Board Of Trustees Of The University Of Illinois |
4-1bb receptors are expressed on regulatory t-cells
|
|
EP2243788A1
(en)
|
2005-02-24 |
2010-10-27 |
Medical Research Council |
HIVCON: An HIV immunogen and uses thereof
|
|
EP1877090B1
(en)
*
|
2005-05-06 |
2014-01-15 |
Providence Health System |
Trimeric ox40-immunoglobulin fusion protein and methods of use
|
|
DK1919954T3
(en)
*
|
2005-08-30 |
2017-01-30 |
Univ Miami |
Immune modulating tumor necrosis factor receptor (TNFR25) - agonists, antagonists and immunotoxins
|
|
WO2007130493A2
(en)
*
|
2006-05-03 |
2007-11-15 |
Regents Of The University Of Colorado |
Cd40 agonist antibody/type1 interferon synergistic adjuvant combination, conjugates containing and use thereof as a therapeutic to enhance cellular immunity
|
|
WO2008108808A2
(en)
*
|
2006-08-24 |
2008-09-12 |
Trustees Of Boston University |
Complexes derived from heterohybrid cells and uses thereof
|
|
US8389282B2
(en)
*
|
2007-03-30 |
2013-03-05 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes
|
|
ITPD20070252A1
(it)
*
|
2007-07-24 |
2009-01-25 |
Primiero Paolo |
Complessi di grp94 ed immunoglobuline g umane
|
|
US9408909B2
(en)
*
|
2007-09-14 |
2016-08-09 |
Vrije Universiteit Brussel |
Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination
|
|
GB0719509D0
(en)
*
|
2007-10-05 |
2007-11-14 |
Isis Innovation |
Molecular adjuvant
|
|
WO2009114085A2
(en)
|
2008-03-03 |
2009-09-17 |
The University Of Miami |
Allogeneic cancer cell-based immunotherapy
|
|
US20090226435A1
(en)
*
|
2008-03-08 |
2009-09-10 |
Sanjay Khare |
Engineered fusion molecules immunotherapy in cancer and inflammatory diseases
|
|
AU2009226077B2
(en)
|
2008-03-20 |
2012-04-19 |
University Of Miami |
Heat shock protein gp96 vaccination and methods of using same
|
|
US9931386B2
(en)
*
|
2008-06-16 |
2018-04-03 |
Atsuo Ochi |
Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity
|
|
EP2358383A4
(en)
|
2008-11-21 |
2011-11-23 |
Univ Miami |
HIV / SIV VACCINES FOR THE MANUFACTURE OF SLEEPAGE AND SYSTEM IMMUNITY
|
|
MX356367B
(es)
|
2008-12-09 |
2018-05-25 |
Genentech Inc |
Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t.
|
|
AU2010232490B2
(en)
*
|
2009-04-03 |
2016-08-11 |
Agenus Inc. |
Methods for preparing and using multichaperone-antigen complexes
|
|
EP2464661B1
(en)
*
|
2009-08-13 |
2018-01-17 |
The Johns Hopkins University |
Methods of modulating immune function with anti-b7-h7cr antibodies
|
|
US9459246B2
(en)
|
2009-09-08 |
2016-10-04 |
Nodality, Inc. |
Induced intercellular communication
|
|
WO2011041613A2
(en)
*
|
2009-09-30 |
2011-04-07 |
Memorial Sloan-Kettering Cancer Center |
Combination immunotherapy for the treatment of cancer
|
|
WO2011069529A1
(en)
|
2009-12-09 |
2011-06-16 |
Curevac Gmbh |
Mannose-containing solution for lyophilization, transfection and/or injection of nucleic acids
|
|
EP2550359B1
(en)
*
|
2010-03-23 |
2017-08-09 |
Intrexon Corporation |
Vectors conditionally expressing therapeutic proteins, host cells comprising the vectors, and uses thereof
|
|
WO2011131472A1
(en)
|
2010-04-22 |
2011-10-27 |
Institut Gustave Roussy |
Compounds and uses thereof to induce an immunogenic cancer cell death in a subject
|
|
WO2011146395A2
(en)
*
|
2010-05-17 |
2011-11-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
|
|
KR20130113953A
(ko)
*
|
2010-05-21 |
2013-10-16 |
유니버시티 오브 마이애미 |
암 치료
|
|
US9234042B2
(en)
*
|
2010-10-18 |
2016-01-12 |
Delphi Genetics Sa |
Method for producing antibody using “naked” expression vector expressing type II transmembrane fusion protein
|
|
CN102462841A
(zh)
*
|
2010-11-09 |
2012-05-23 |
中国科学院微生物研究所 |
一种促进gp96蛋白的免疫活性的方法及其应用
|
|
AU2012220592A1
(en)
*
|
2011-02-23 |
2013-09-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Service |
Combined cell based GP96-IG-SIV/HIV, recombinant GP120 protein vaccination for protection from SIV/HIV
|
|
AU2012262520A1
(en)
|
2011-05-27 |
2014-01-23 |
Cytocure Llc |
Methods, compositions, and kits for the treatment of cancer
|
|
BR112014014591A8
(pt)
*
|
2011-12-12 |
2017-07-04 |
Baylor College Medicine |
processo para a expansão in vitro de células t específicas de antígeno, produto de células t autólogas ou alogênicas expandidas, composição farmacêutica, e, método de tratamento de um paciente, e, usos de uma linhagem de células engenheirada, de células dendríticas pulsadas com misturas de antígeno-peptídeo, de t-apcs pulsadas com misturas de antígeno-peptídeo/peptídeo, e de misturas de antígeno-peptídeo com pbmcs
|
|
EA032389B1
(ru)
*
|
2012-02-14 |
2019-05-31 |
Мериал, Инк. |
Рекомбинантные поксвирусные векторы, кодирующие и экспрессирующие гликопротеин g вируса бешенства и полипептид oxl, и вакцины, созданные на их основе, используемые в способе вакцинации животных против бешенства
|
|
SMT201900242T1
(it)
*
|
2012-12-03 |
2019-05-10 |
Bristol Myers Squibb Co |
Incremento dell'attivita' anti-cancro di proteine di fuzione a fc immunomodulatrici
|
|
WO2014106602A1
(en)
*
|
2013-01-02 |
2014-07-10 |
Glenmark Pharmaceuticals S.A. |
Antibodies that bind to tl1a and their uses
|
|
EP2943253B1
(en)
*
|
2013-01-09 |
2021-10-20 |
University Of Miami |
Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein and il-2
|
|
EP2951209A4
(en)
*
|
2013-01-31 |
2016-06-22 |
Univ Jefferson |
CD40 OX40 AGONIST FUSION PROTEIN AND USES THEREOF
|
|
WO2014140884A2
(en)
|
2013-03-15 |
2014-09-18 |
Novelogics Biotechnology, Inc. |
Methods and devices for removal of immunosuppressive ligands
|
|
WO2014140904A2
(en)
|
2013-03-15 |
2014-09-18 |
Novelogics Biotechnology, Inc. |
Antibodies to mica and micb proteins
|
|
US10196435B2
(en)
*
|
2013-11-18 |
2019-02-05 |
University Of Southern California |
OX40L fusion protein for the immunotherapy of tumors of veterinary animals
|
|
CN114317461A
(zh)
*
|
2013-11-22 |
2022-04-12 |
德那翠丝有限公司 |
表达免疫细胞刺激受体激动剂的腺病毒
|
|
JP7060324B2
(ja)
*
|
2013-12-20 |
2022-04-26 |
ザ・ブロード・インスティテュート・インコーポレイテッド |
ネオ抗原ワクチンによる併用療法
|
|
WO2015131176A1
(en)
*
|
2014-02-28 |
2015-09-03 |
Podack Eckhard R |
Compositions, methods, and kits for treatment of cancer
|
|
SG10201808746QA
(en)
*
|
2014-04-03 |
2018-11-29 |
Augusta University Research Institute Inc |
Methods for enhancing the efficacy of a tumor-directed immune response
|
|
CN106456734A
(zh)
*
|
2014-05-29 |
2017-02-22 |
免疫医疗有限责任公司 |
Ox40l融合蛋白及其用途
|
|
MA41414A
(fr)
*
|
2015-01-28 |
2017-12-05 |
Centre Nat Rech Scient |
Protéines de liaison agonistes d' icos
|
|
MA41460A
(fr)
*
|
2015-02-03 |
2017-12-12 |
Oncomed Pharm Inc |
Agents de liaison à la tnfrsf et leurs utilisations
|
|
US10046047B2
(en)
*
|
2015-02-06 |
2018-08-14 |
Heat Biologics, Inc. |
Vector co-expressing vaccine and costimulatory molecules
|
|
EP3292152A1
(en)
*
|
2015-05-07 |
2018-03-14 |
Agenus Inc. |
Anti-ox40 antibodies and methods of use thereof
|
|
RU2746314C2
(ru)
*
|
2016-06-09 |
2021-04-12 |
Пеликан Терапьютикс, Инк. |
Антитела анти-tnfrsf25
|
|
WO2018187260A1
(en)
*
|
2017-04-04 |
2018-10-11 |
Heat Biologics, Inc. |
Intratumoral vaccination
|
|
JP2021504329A
(ja)
*
|
2017-11-27 |
2021-02-15 |
ヒート バイオロジクス，インコーポレイテッド |
Ｇｐ９６ベースの癌療法
|
|
EP3860647A4
(en)
*
|
2018-10-01 |
2022-10-19 |
Heat Biologics, Inc. |
CELL-BASED COMBINATION THERAPIES
|
|
EP4019536A4
(en)
*
|
2019-08-19 |
2023-09-06 |
Nantong Yichen Biopharma. Co. Ltd. |
Immunocytokine, preparation for same, and uses thereof
|
|
WO2021178416A1
(en)
*
|
2020-03-02 |
2021-09-10 |
Heat Biologics, Inc. |
Immune-mediated coronavirus treatments
|